Marwan Kwok
机构: CRUK Clinician Scientist, University of Birmingham & Dana-Farber Cancer Institute
每年引用次数
引用次数
引用: 1,619
H-指数: 12
I10-指数 : 12
出版物: 40
ATR Inhibition Exacerbates Replication Stress in TP53 or ATM Deficient CLL Cells and Enhances Sensitivity to Chemotherapy and Targeted Therapy
Marwan Kwok , Nicholas Davies , Angelo Agathanggelou , Edward Smith
Blood 124 ( 21) 3340 -3340
1
2014
Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia
Andy C. Rawstron , Fiona L. Bennett , Sheila J.M. O'Connor , Marwan Kwok
The New England Journal of Medicine 359 ( 6) 575 -583
479
2008
PALB2 variant status in hematological malignancies - a potential therapeutic target?
Ceri E Oldreive , Philip J Byrd , Grant S Stewart , Alexander J Taylor
Leukemia & Lymphoma 60 ( 7) 1823 -1826
1
2019
Synthetic lethality in chronic lymphocytic leukaemia with DNA damage response defects by targeting the ATR pathway
Marwan Kwok , Nicholas Davies , Angelo Agathanggelou , Edward Smith
The Lancet 385
54
2015
Genome-scale clustered regularly interspaced short palindromic repeats screen identifies nucleotide metabolism as an actionable therapeutic vulnerability in diffuse large B-cell lymphoma
Nicholas Davies , Tegan Francis , Ceri Oldreive , Maria Azam
Haematologica
2020
Targeting the p53 pathway in CLL: State of the art and future perspectives
Marwan Kwok , Angelo Agathanggelou , Nicholas Davies , Tatjana Stankovic
Cancers 13 ( 18) 4681 -4681
16
2021
Ibrutinib: another string to its bow
Tatjana Stankovic , Marwan Kwok
Blood, The Journal of the American Society of Hematology 137 ( 25) 3461 -3462
2
2021
DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies
Marwan Kwok , Angelo Agathanggelou , Tatjana Stankovic
Blood 143 ( 21) 2123 -2144
2024
CLL patients: GIVe me three!
Marwan Kwok , Tatjana Stankovic
Blood 142 ( 11) 941 -943
2023
Linking epigenome regulation with DNA repair
Tatjana Stankovic , Marwan Kwok
Blood, The Journal of the American Society of Hematology 139 ( 23) 3356 -3357
2022
The three musketeers: uniting against CLL
Marwan Kwok , Tatjana Stankovic
Blood 139 ( 9) 1264 -1265
2022
Correction: Kwok et al. Targeting the p53 Pathway in CLL: State of the Art and Future Perspectives. Cancers 2021, 13, 4681
Marwan Kwok , Angelo Agathanggelou , Nicholas Davies , Tatjana Stankovic
Cancers 14 ( 2) 321 -321
2022
Targeting the p53 Pathway in CLL: State of the Art and Future Perspectives (vol 13, 4681, 2021)
Marwan Kwok , Angelo Agathanggelou , Nicholas Davies , Tatjana Stankovic
CANCERS 14 ( 2)
2022
Targeting the p53 Pathway in CLL
Marwan Kwok , Angelo Agathanggelou , Nicholas Davies , Tatjana Stankovic
2021
Blood First Edition Paper, prepublished online October 3, 2016; DOI 10.1182/blood-2016-05-714162
Marwan Kwok , Andy C Rawstron , Abraham Varghese , Paul AS Evans
2016
Clonal evolution of high-risk chronic lymphocytic leukemia: A contemporary perspective
Marwan Kwok , Catherine J Wu
Frontiers in oncology 11 790004 -790004
15
2021
In Focus Cancer and COVID-19: On the Quest for Effective Vaccines
Marwan Kwok , Edward F Fritsch , Catherine J Wu
2020
Zoledronate inhibits proliferation and induces apoptosis of imatinib-resistant chronic myeloid leukaemia cells
C Chuah , D J Barnes , M Kwok , A Corbin
Leukemia 19 ( 11) 1896 -1904
48
2005
Outcomes following treatment discontinuation in CML: real-world experience from 3 regional UK centres: PB1946
M Kwok , A Shenouda , N Duncan , Y Hasan
HemaSphere 3 884 -885
1
2019
Outcomes following treatment discontinuation in chronic myeloid leukaemia (CML): real-world experience from three regional UK centres
F Wandroo , M Raghavan , J Ewing , M Kwok
BRITISH JOURNAL OF HAEMATOLOGY 189 183 -183
2020